Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 30 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Jitka S.

Czech Republic

USD 30 /hr

Scientific / Medical / Proposal Writer

Profile Summary

During my PhD at Cardiff University, UK, I was developing novel inhibitors for metastatic breast cancer. My research of Bcl-3 inhibitors led to a patent filing and a foundation of a start up company, Tiziana Lifesciences. Later I moved to Spain as a Postdoctoral researcher of Marie Curie International Training Network to study novel therapies for metastatic liver cancer, focusing on the importance of metabolism in metastatic cancer progression. During my academic experience I realised that I enjoy more the scientific writing part than actual research and went on establishing my career as a scientific/medical writer. Currently I am mainly writing research proposals for Horizon 2020 funding, market research for health related projects and creating health related content for medical doctors.

Subject Matter Expertise

• ☆ Molecular Biology
• ☆ Medicine
• ☆ Oncology
• ☆ Cancer Research
• ☆ Medical Writing
• ☆ Technical & Scientific Writing

Services

• Writing
• Consulting
• Product Development

Work Experience

Medical Writer

Kalispera

November 2018 - Present

Senior Healthcare analysist

Toro Ventures

July 2018 - Present

Proposal Writer for Horizon 2020

Inspiralia

July 2018 - Present

Postdoctoral Researcher

Institut d'Investigacio Biomedica de Bellvitge

October 2014 - April 2017

Education

Scientific departments in Pharmaceutical Industry

University of Barcelona

October 2017 - Present

Master of Pharmacy (Faculty of Pharmacy and Pharmaceutical Sciences)

Univerzita Karlova

October 2005 - June 2010

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Rani B, Malfettone A, Dituri F, Soukupova J, Lupo L, Mancarella S, Fabregat I, Giannelli G(2018). Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression . Cell death & disease.

(2017). Resminostat induces changes in epithelial plasticity of hepatocellular carcinoma cells and sensitizes them to sorafenib-induced apoptosis . Oncotarget.

(2017). Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism . Scientific reports.

(2017). Hybrid polymeric-protein nano-carriers (HPPNC) for targeted delivery of TGFβ inhibitors to hepatocellular carcinoma cells . Journal of materials science. Materials in medicine.

Fabregat I, Malfettone A, Soukupova J, Journal of clinical medicine, 2016, vol. 5, no. 3, 2016 .

Wakefield A, Soukupova J, Montagne A, Ranger J, French R, Muller WJ, Clarkson RW, Cancer research, 2013, vol. 73, no. 2, pp. 745-755, 2013 .

Brahemi G, Kona FR, Fiasella A, Buac D, Soukupová J, Brancale A, Burger AM, Westwell AD, Journal of medicinal chemistry, 2010, vol. 53, no. 7, pp. 2757-2765, 2010 .